While many states have granted permission for health-related marijuana use, it remains classified like a Agenda 1 drug less than federal requirements, lacking acknowledged clinical purposes and posing an important danger of abuse. Moreover, as per the American Modern society of Scientific Oncology's 2017 rules, there is inadequate proof to advi